Dr. Maria Voznesensky, MD

Dr. Voznesensky practices at St. Peter's Health Partners Medical Associates in Albany, New York.

Dr. Voznesensky's NPI, 1831419514, was assigned on June 4, 2010. Dr. Voznesensky graduated from University of Connecticut in 2010. Dr. Voznesensky holds New York license 306661.

Dr. Voznesensky's primary practice is St. Peter's Health Partners Medical Associates, at 319 S Manning Blvd, Albany, NY 12208 in Albany County. The practice phone is (518) 525-5634.

Dr. Voznesensky's primary practice is St. Peter's Health Partners Medical Associates in Albany, New York. Dr. Voznesensky is also affiliated with St. Peter's Hospital. The medical group on file is St. Peter's Medical Associates. Dmand AI also links Dr. Voznesensky to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Voznesensky practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Voznesensky's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Voznesensky's licenses on file in 3 states: New York, Iowa and Pennsylvania.

CMS data shows 771 Medicare services from Dr. Voznesensky across 14 procedure codes in 2024, for 368 Medicare patients. Medicare paid $75,475 for them.

CMS counts 368 Medicare patients who saw Dr. Voznesensky in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Voznesensky's median patient age at 71, with 36% women.

In 2024, Dr. Voznesensky wrote 537 Medicare Part D claims for 230 patients. 91% of them were for generic drugs. CMS names the drug for 407 of them, across 13 drugs with 11 or more claims each, at $50,785 in total drug cost. In 2023, CMS named 467 claims across 13 drugs.

Dr. Voznesensky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Voznesensky as offering telehealth. CMS counts 38 procedures of prostate resection by Dr. Voznesensky, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Voznesensky, published from 2015 to 2017. Dr. Voznesensky has published most often in Can J Urol. Dr. Voznesensky's most frequent co-authors are Nejd F. Alsikafi, MD, Mark D. Bevill, MD and Benjamin Newell Breyer, MD.

CMS Open Payments shows 374 general payments to Dr. Voznesensky from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $4,942.

Dr. Voznesensky graduated from University of Connecticut in 2010.